Loading...
XNAS
LSB
Market cap38mUSD
Jul 28, Last price  
0.93USD
1D
-18.91%
1Q
-22.00%
Name

YS Biopharma Co Ltd

Chart & Performance

D1W1MN
XNAS:LSB chart
No data to show
P/E
P/S
0.07
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
573m
-16.56%
257,015,929502,949,894687,201,070573,418,256
Net income
-433m
L+197.96%
-191,826,242-106,004,401-145,479,105-433,464,871
CFO
-295m
L+61.80%
-246,610,437-173,545,357-182,469,396-295,229,603

Profile

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
IPO date
Employees
773
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2024‑032023‑032022‑032021‑03
Income
Revenues
573,418
-16.56%
687,201
36.63%
Cost of revenue
848,583
805,382
Unusual Expense (Income)
NOPBT
(275,164)
(118,181)
NOPBT Margin
Operating Taxes
(21,729)
1,134
Tax Rate
NOPAT
(253,436)
(119,315)
Net income
(433,465)
197.96%
(145,479)
37.24%
Dividends
Dividend yield
Proceeds from repurchase of equity
284,196
BB yield
-3,692.11%
Debt
Debt current
323,697
198,490
Long-term debt
107,708
311,242
Deferred revenue
20,280
23,607
Other long-term liabilities
4,548
8,792
Net debt
185,054
139,624
Cash flow
Cash from operating activities
(295,230)
(182,469)
CAPEX
(44,251)
(57,050)
Cash from investing activities
(44,251)
(56,982)
Cash from financing activities
205,261
317,450
FCF
(131,644)
(214,837)
Balance
Cash
246,351
370,108
Long term investments
Excess cash
217,680
335,748
Stockholders' equity
(2,365,657)
(1,928,438)
Invested Capital
3,400,156
3,187,920
ROIC
ROCE
EV
Common stock shares outstanding
10,692
77,422
Price
0.72
-55.01%
1.60
 
Market cap
7,697
-93.79%
123,875
 
EV
192,751
263,499
EBITDA
(232,979)
(81,493)
EV/EBITDA
Interest
44,345
30,858
Interest/NOPBT